Raffaele Baffa - May 17, 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Chief Medical Officer
Signature
/s/ Robert Hadfield, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
May 17, 2021
Transactions value $
$0
Form type
4
Date filed
5/19/2021, 04:55 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Award $0 +80.6K +40.32% $0.00 281K May 17, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third of the shares vest on each of September 1, 2021, February 1, 2022 and May 1, 2022, subject to the Reporting Person's continued service through each such date.